The lessons of the COVID-19 pandemic will be examined for years to come, but one message is already clear: the value of large platform trials involving multiple potential treatments in a single protocol.
Specifically, the United Kingdom’s RECOVERY (Randomised Evaluation of COVID-19 Therapy) trial, which has now delivered three definitive outcomes just...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?